Acute mountain sickness prediction: a concerto of multidimensional phenotypic data and machine learning strategies in the framework of predictive, preventive, and personalized medicine
EPMA Journal · 31.03.2025 · 16 (2) · 265-284
DOI: 10.1007/s13167-025-00404-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift EPMA Journal, online erschienen am 31.03.2025. Verfasst von Wenhui Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for High Altitude Medicine, Qinghai Provincial Key Laboratory of Plateau Medical Application, Key Laboratory of Ministry of Education…. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State Administration of Traditional Chinese Medicine of the People's Republic of China, China Association for Science and Technology.
Abstract (Originalsprache)
Background
Acute mountain sickness (AMS) is a self-limiting illness, involving a complex series of physiological responses to rapid ascent to high altitudes, where the body is exposed to lower oxygen levels (hypoxia) and changes in atmospheric pressure. AMS is the mildest and most common form of altitude sickness; however, without adequate preparation and adherence to ascent guidelines, it can progress to life-threatening conditions.
Aims
Due to the multi-factorial predisposition of AMS among individuals, identifying AMS biomarkers before high altitude exposure from multiple dimensions (e.g., clinical, metabolic, and proteomic markers) and integrating them to build an AMS predictive model enables early diagnosis and personalized interventions, which allows targeted allocation of medical resources, such as prophylactic medications (e.g., acetazolamide) and supplemental oxygen, to those who need them most and prevention of unnecessary complications. Consequently, predicting AMS utilizing biomarkers from multidimensional phenotypic data before high-altitude exposure is essential for the paradigm change in high-altitude medical research from currently applied reactive services to the cost-effective predictive, preventive, and personalized medicine (PPPM/3PM) in primary (reversible damage to health and targeted protection against health-to-disease transition) and secondary (personalized protection against disease progression) care.
Methods
To this end, this study recruited 83 Han Chinese male volunteers and obtained clinical, proteomic, and metabolomic profiles for analysis before they ascended to high altitudes. The Mann–Whitney U test was used to identify clinical features distinguishing AMS from non-AMS. The proteomic and metabolomic features were concatenated and clustered to find co-expression modules associated with AMS. A machine learning model, Mutual Information-radial kernel-based Support Vector Machine-Recursive Feature Elimination (MI-radialSVM-RFE) was employed for biomarkers selection and AMS prediction. A molecular docking technique was used to select molecular biomarkers that can bind with Traditional Chinese Medicine (TCM) ingredients.
Results
Among 83 participants, 66 were selected for detailed analysis after quality control steps. Six protein-metabolite co-expression modules were identified as significantly associated with AMS. The MI-radialSVM-RFE model selected 12 biomarkers (two clinical features: systolic blood pressure (SBP) and peak expiratory flow (PEF); six proteins: Acyl-CoA synthetase long-chain family member 4 (ACSL4), immunoglobulin kappa variable 1D-16 (IGKV1D-16), coagulation factor XIII B subunit (F13B), prosaposin (PSAP), poliovirus receptor (PVR), and multimerin-2 (MMRN2); and four metabolites: 2-Methyl-1,3-cyclohexadiene, calcitriol, 4-Acetamido-2-amino-6-nitrotoluene, and 20-Hydroxy-PGE2) for the AMS prediction model. The model exhibited excellent predictive performance in both training ( n = 66) and validating cohorts ( n = 24) with AUCs of 0.97 and 0.94, respectively. Additionally, molecular docking analysis suggested PSAP and ACSL4 proteins as potential molecular targets for AMS prevention. Conclusion and expert recommendations This study advances high-altitude medicine by developing a predictive model for AMS using clinical, proteomic, and metabolomic data. The identified biomarkers linked to energy metabolism, immune response, and vascular regulation offer insights into AMS mechanisms. High-altitude predictive approaches should focus on implementing biomarker-driven risk screening using clinical, proteomic, and metabolomic data to identify high-risk individuals before high-altitude exposure. Preventive measures should prioritize pre-acclimatization protocols, tailored nutritional strategies and interventions guided by biomarker profiles, and lifestyle adjustments, such as maintaining mitochondrial health through proper nutritional strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Center for High Altitude Medicine, Qinghai Provincial Key Laboratory of Plateau Medical Application, Key Laboratory of Ministry of Education, Qinghai-Utah Joint Research Key Laboratory for High Altitude Medicin…
- The Fifth People's Hospital of Qinghai Province, Xining, 810000 China.
- Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing, 100850 China.
- Qinghai Provincial Key Laboratory of Traditional Chinese Medicine Research for Glucolipid Metabolic Diseases, Qinghai University, Xining, 810000 China.
- State Key Laboratory of Kidney Diseases, Chinese PLA General Hospital, Beijing, 100853 China.
Förderung
- State Administration of Traditional Chinese Medicine of the People's Republic of China
- China Association for Science and Technology
Zitieren
APA
Li, W., Zhang, M., Hu, Y., Shen, P., Bai, Z., Huangfu, C., Ni, Z., Sun, D., Wang, N., Zhang, P., Tong, L., Gao, Y., & Zhou, W. (2025). Acute mountain sickness prediction: a concerto of multidimensional phenotypic data and machine learning strategies in the framework of predictive, preventive, and personalized medicine. EPMA Journal, 16(2), 265-284. https://doi.org/10.1007/s13167-025-00404-9
Vancouver
Li W, Zhang M, Hu Y, Shen P, Bai Z, Huangfu C, et al. Acute mountain sickness prediction: a concerto of multidimensional phenotypic data and machine learning strategies in the framework of predictive, preventive, and personalized medicine. EPMA Journal. 2025;16(2):265-284. doi:10.1007/s13167-025-00404-9
BibTeX
@article{Li2025,
author = {Li, Wenhui and Zhang, Meng and Hu, Yangyi and Shen, Pan and Bai, Zhijie and Huangfu, Chaoji and Ni, Zhexin and Sun, Dezhi and Wang, Ningning and Zhang, Pengfei and Tong, Li and Gao, Yue and Zhou, Wei},
title = {Acute mountain sickness prediction: a concerto of multidimensional phenotypic data and machine learning strategies in the framework of predictive, preventive, and personalized medicine},
journal = {EPMA Journal},
year = {2025},
volume = {16},
number = {2},
pages = {265--284},
doi = {10.1007/s13167-025-00404-9}
}
EUVIMED